Business Standard

Jubilant Life Sciences standalone net profit declines 53.26% in the September 2016 quarter

Image

Capital Market

Sales decline 18.69% to Rs 566.23 crore

Net profit of Jubilant Life Sciences declined 53.26% to Rs 24.12 crore in the quarter ended September 2016 as against Rs 51.61 crore during the previous quarter ended September 2015. Sales declined 18.69% to Rs 566.23 crore in the quarter ended September 2016 as against Rs 696.40 crore during the previous quarter ended September 2015. ParticularsQuarter EndedSep. 2016Sep. 2015% Var.Sales566.23696.40 -19 OPM %13.4912.28 -PBDT55.2271.50 -23 PBT35.0349.30 -29 NP24.1251.61 -53

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Oct 28 2016 | 7:57 AM IST

Explore News